AWARDPURCHASE ORDERSmall business
Purchase order 75F40118P20106WE PHARMA, INC.
Overview
Award facts
- Net obligations
- $214.91K
- $214,915of $214.91K potential value
- Outlays (paid to date)
- $0
- $0 paid of $214.91K obligated$0
- Period of performance
- Jun 29, 2018 to Jul 15, 2020
- Ended
- Modifications
- 4
- Latest action Jun 24, 2025
- Contract type
- Purchase order
- PIID 75F40118P20106
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
PHYSICOCHEMICAL PRODUCTS
Dates and value
- Award date
- Signed on Jun 29, 2018
- Potential end of performance
- Jul 14, 2020
- Current value
- $214,915Base and exercised options
- Potential value (if all options are exercised)
- $214,915
Obligations by fiscal year of action
- FY2025: -$85 (de-obligation)
- FY2019: $85,000
- FY2018: $130,000
Total across 3 fiscal years: $214,915
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 24, 2025. View on USAspending · Recipient on SAM.gov
Recipient
NameWE PHARMA, INC.
LocationMORRISVILLE, NC
UEIEWAMVJSFNK29
CAGE code7CN54
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyWE PHARMA, INC.
Business types and certifications
Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Morrisville, Wake County, North Carolina 27560-6637
- Congressional district (place of performance)
- NC-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- FDA_182331194856(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 29, 2018Base obligation at award: $30,000
- Latest action
- Jun 24, 2025 — CloseoutModification P00004; obligation change -$85; administrative: no change in scope or value
- Latest substantive action
- Feb 14, 2019 — Option exercisedModification P00003; obligation change +$50,000
- Latest funding action
- Aug 13, 2018 — Funding onlyModification P00001; obligation change +$100,000; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only1
- Option exercised1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$85
- Latest action: change in base and all options
- -$150,085
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression